 |
8 Diseases |  |
2 Trials |
|
2 Trials |  |
2 News |  |
- CART-33 / Chinese PLA General Hospital
New P1 trial: Allogeneic CART-33 for Relapsed/Refractory CD33+ AML (clinicaltrials.gov) - Jun 16, 2016
P1, N=12, Recruiting, Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- CART-33 / Chinese PLA General Hospital
New P1/2 trial: Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33 (clinicaltrials.gov) - May 28, 2013
P1/2, N=10, Recruiting, Sponsor: Chinese PLA General Hospital